The Correlation Between Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) and miR‐142‐3p in Maintenance Hemodialysis Patients With End‐Stage Renal Disease

Abstract

ABSTRACTBackgroundPatients with end‐stage renal disease (ESRD) on maintenance hemodialysis (MHD) are at high risk for major adverse cardiovascular and cerebrovascular events (MACCE), which are prone to be detrimental to patients' lives. Identifying risk factors for MACCE can help target measures to prevent or reduce the occurrence of MACCE.ObjectiveThe aim was to investigate the correlation between miR‐142‐3p and MACCE in ESRD patients on MHD and to provide a new predictor for MACCE occurrence.MethodsBlood samples were collected from subjects to detect the expression of miR‐142‐3p using RT‐qPCR. The correlation of miR‐142‐3p with HDL‐C and hs‐CRP was assessed by the Pearson method. The occurrence of MACCE in patients during the 36‐month follow‐up period was recorded. The clinical value of miR‐142‐3p in MACCE occurrence was analyzed by the Kaplan–Meier curve, multivariate logistic regression, and ROC curve.ResultsIn ESRD patients on MHD, miR‐142‐3p was downregulated, and it showed a positive correlation with HDL‐C but a negative correlation with hs‐CRP. The cumulative incidence of MACCE at 1, 2, and 3 years was 8.9%, 20.0%, and 30.4%, respectively. miR‐142‐3p levels were reduced in patients who developed MACCE and were associated with the cumulative incidence of MACCE. miR‐142‐3p was a risk factor for MACCE and showed a predictive value with specificity and sensitivity of 89.36% and 56.10%, respectively.ConclusionsmiR‐142‐3p was a risk factor of MACCE in ESRD patients undergoing MHD.